Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor
(NASDAQ: PRAX) Delayed: 266.58 +18.60 (7.50%)
Previous Close $247.98    52 Week High $ 
Open $247.26    52 Week Low $ 
Day High $269.40    P/E N/A 
Day Low $247.26    EPS $ 
Volume 423,154